Connect your AI

Medtronic MDT FX & Other Adjustments

FX & Other Adjustments at other companies

TFX

TeleflexTFX

-$10.99M-182%

LivaNovaLIVN

$10.71M+230%

CONMEDCNMD

——

Segments

By segment

Medical Surgical$110M-84.8%

Neuroscience$20M-81.1%

Cardiovascular$10M-88.6%

Diabetes$0—

Other Operating Segments$0-100%

Other financials

Income statement

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

Market cap$103.01B-10.1%

Enterprise value$130.27B-8.3%

P/E21.5×-3.1×

P/S2.8×-0.6×

Profitability

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's fx & other adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medtronic's FX & other adjustments?: Medtronic (MDT) reported FX & other adjustments of $82M in Q4 2025.
How has Medtronic's FX & other adjustments changed year-over-year?: Medtronic's FX & other adjustments increased by 118.1% year-over-year, from -$453M to $82M.